Published in Medical Letter on the CDC and FDA, September 10th, 2006
Researchers in the United States conducted a study "to measure human papillomavirus (HPV) 6 and 11 viral load and antibody response in longitudinal specimens obtained from children with recurrent respiratory papillomatosis and to examine the association of type-specific viral load with clinical severity of disease."
"The study included 15 children undergoing therapy for recurrent respiratory papillomatosis at the Egleston Children's Hospital (Atlanta, Georgia) between January 22, 1999, and June 13, 2000,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.